Success Metrics

Clinical Success Rate
91.7%

Based on 44 completed trials

Completion Rate
92%(44/48)
Active Trials
18(23%)
Results Posted
11%(5 trials)
Terminated
4(5%)

Phase Distribution

Ph not_applicable
63
82%
Ph phase_4
2
3%
Ph phase_1
3
4%

Phase Distribution

3

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution68 total trials
Phase 1Safety & dosage
3(4.4%)
Phase 4Post-market surveillance
2(2.9%)
N/ANon-phased studies
63(92.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.0%

44 of 50 finished

Non-Completion Rate

12.0%

6 ended early

Currently Active

18

trials recruiting

Total Trials

77

all time

Status Distribution
Active(21)
Completed(44)
Terminated(6)
Other(6)

Detailed Status

Completed44
Recruiting16
unknown6
Terminated4
Withdrawn2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
77
Active
18
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (4.4%)
Phase 42 (2.9%)
N/A63 (92.6%)

Trials by Status

recruiting1621%
withdrawn23%
active_not_recruiting23%
terminated45%
enrolling_by_invitation23%
completed4457%
not_yet_recruiting11%
unknown68%

Recent Activity

Clinical Trials (77)

Showing 20 of 77 trialsScroll for more
NCT06307275Not Applicable

Intermittent Fasting on Body Fat and Quality of Life

Recruiting
NCT07527208Not Applicable

The Meta-SHIFT Study: How Metabolic Shift Shapes Human Immunometabolism - a Fasting Trial

Not Yet Recruiting
NCT06424132Not Applicable

Thermogenic Silencer Regulatory Factors in Humans

Active Not Recruiting
NCT06425731Not Applicable

Dance and Energy Expenditure Among Adults With Parkinson's

Recruiting
NCT07009288Not Applicable

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Recruiting
NCT07508293

Continuous Enteral Feeding Until Tracheostomy and Aspiration Risk

Completed
NCT06172088Not Applicable

Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy

Completed
NCT05819801Not Applicable

Effect of Fasting on Patient Outcomes After Wide-Awake, Local Anesthesia-only, No Tourniquet (WALANT) Procedures

Recruiting
NCT06645093Not Applicable

Feasibility of Intermittent Fasting During Chemotherapy

Enrolling By Invitation
NCT05545306Not Applicable

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Recruiting
NCT06751043Not Applicable

Preoperative Fasting vs. Not Fasting in Critically Ill Patients

Recruiting
NCT06115148Not Applicable

Breath Analysis & Malnutrition

Recruiting
NCT06996639Not Applicable

Breaking Fasts Ahead of Cardiac Caths

Recruiting
NCT07250191Not Applicable

The Effects of 24-hour Fasting or Carbohydrate Restriction on Postprandial Metabolic Responses

Completed
NCT07216989

Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting

Recruiting
NCT07178106Not Applicable

Investigation of the Relationship Between Peripheral and Central Metabolic Changes Caused by Fasting

Completed
NCT07175740Not Applicable

Effect of Macronutrients on Post-Exercise Glycemic Response in Males With Type 2 Diabetes

Completed
NCT06789172Phase 1

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Recruiting
NCT06536881Not Applicable

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

Recruiting
NCT05764330Not Applicable

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Completed

Drug Details

Intervention Type
OTHER
Total Trials
77